# Janux Therapeutics, Inc.: Form SC 13D/A, filed Sep 16, 2024

- Company: [Janux Therapeutics, Inc.](/companies/janx.md) (CIK 1817713)
- Form: SC 13D/A
- Filed: 2024-09-16
- Accepted by EDGAR: Sep 16, 2024, 21:35 ET
- Period: not reported
- Accession: 0001104659-24-100346
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1817713/000110465924100346/tm2424209d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817713/000110465924100346/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817713/000110465924100346/tm2424209d1_sc13da.htm

Filed Sep 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-100346. Last ingested by Listed: Nov 5, 2026, 18:20 ET. No prices; not investment advice.